Racial Disparities Seen in Unintentional Overdose Mortality

Medically reviewed by Carmen Pope, BPharm. Last updated on April 9, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, April 9, 2025 -- There are disparities in overdose mortality, with a pronounced and increasing burden of mortality for Black men and Black women, according to a study published online April 1 in JAMA Network Open.

Kechna Cadet, Ph.D., M.P.H., from the Columbia University Mailman School of Public Health in New York City, and colleagues examined intersectional sex-specific White and Black racial disparities in drug poisoning mortality across states from 2010 to 2020 in a cross-sectional study using unintentional fatal drug poisoning mortality data.

Overall, 11,820,781 years of potential life lost (YPLL) were recorded from a total sample of 518,724 unintentional fatal drug poisoning deaths. The highest mean age-adjusted mortality rate was seen for Black men (23.25), followed by White men, White women, and Black women (22.49, 11.71, and 9.01, respectively). Compared with White men, both Black men and Black women had worsening YPLL over time, while White women showed improvement in YPLL over time (τ = 0.298, 0.157, and −0.146, respectively). There was a disproportionate burden of deaths due to drug poisonings at the state level; the highest increase in mortality rates among Black men was seen in Maryland (485.4 percent), while states such as Alaska had decreases for White women (−23.0 percent).

"Efforts to reduce drug-related mortality must address the specific needs of marginalized communities, especially Black men," Cadet said in a statement. "Addressing these disparities requires a comprehensive, multifaceted approach that targets social, economic, physical, and policy risk factors."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords